Noninvasive Tests for Liver Fibrosis in Chronic Hepatitis B Virus

AbstractPurpose of ReviewHepatitis B virus (HBV) can be a potentially life-threatening liver infection. Prior to starting therapy, the first step is to establish the diagnosis, then to assess disease severity and determine if treatment is indicated. Assessing the degree of liver fibrosis is imperative to guiding treatment options. While liver biopsy has been the primary method to establish the degree of fibrosis, noninvasive tests (NIT) have now replaced liver biopsy as the initial step.Recent FindingsHere, we present a recent review of literature on NIT to assess liver fibrosis in chronic HBV from 2019 to 2022.SummaryBeing able to use NIT (blood- and/or imaging-based) to assess fibrosis and help guide treatment can help impact and lower disease burden as well as life-threatening complications of liver disease.
Source: Current Hepatitis Reports - Category: Infectious Diseases Source Type: research